Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M728Revenue $M0.3Net Margin (%)-28,347.7Z-Score41.2
Enterprise Value $M566EPS $-1.3Operating Margin %-22,113.6F-Score4
P/E(ttm))0Cash Flow Per Share $-1.1Pre-tax Margin (%)-28,465.9Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %-15.3Quick Ratio19.8Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-20.0Current Ratio19.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-43.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-47.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M51.9ROI % (ttm)-93.0Gross Margin Increase y-yN

Gurus Latest Trades with ARWR

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARWRGeorge Soros 2014-06-30 Sold Out -0.01%$9.79 - $18.28
($13.09)
$ 15.0415%Sold Out0
ARWRGeorge Soros 2014-03-31 Buy 0.01%$9.92 - $26.57
($17.36)
$ 15.04-13%New holding, 44200 sh.44,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARWR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ARWR George Soros 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ARWR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GIVEN DOUGLAS BDirector 2014-08-15Sell5,000$13.98.2view
Myszkowski Kenneth AllenCFO 2014-08-15Sell40,000$14.027.28view
McKenney CharlesDirector 2014-06-09Sell22,000$14.325.03view
Myszkowski Kenneth AllenCFO 2014-02-12Sell16,000$18.77-19.87view
FRYKMAN EDWARD WDirector 2014-02-07Sell3,148$15.98-5.88view
Lewis David L.Chief Scientific Officer 2014-01-02Sell15,000$10.2946.16view

Press Releases about ARWR :

    Quarterly/Annual Reports about ARWR:

    News about ARWR:

    Articles On GuruFocus.com
    Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 10 2011 
    Weekly CFO Buys Highlight: JAZZ, VRTB, ASTM, ARWR, CGX Sep 04 2010 
    Arrowhead Research Corp. Reports Operating Results (10-Q) May 13 2010 
    Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 11 2010 
    Arrowhead Research Corp. Reports Operating Results (10-K) Dec 22 2009 
    Arrowhead Research Corp. Reports Operating Results (10-Q) Aug 10 2009 
    Arrowhead Reports Third Quarter Fiscal 2009 Financial Results Aug 10 2009 
    Arrowhead Research Corp. Reports Operating Results (10-Q) May 15 2009 
    Arrowhead Research Corp. Reports Operating Results (10-Q) Feb 09 2009 
    Arrowhead Reports First Quarter Fiscal 2009 Financial Results Feb 09 2009 

    More From Other Websites
    Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global... Sep 30 2014
    Arrowhead to Present at BioCentury’s NewsMakers in the Biotech Industry Conference Sep 19 2014
    3 Biotech Breakout Charts That Could See More Upside Next Week Sep 11 2014
    Arrowhead Research Corp Heads Higher After Breakout Sep 04 2014
    Arrowhead Research Climbs +8.54% Midday, Is Up Over +50% YTD Sep 03 2014
    Arrowhead Research Corp Shares Push Over Resistance Level As Momentum Continues Sep 03 2014
    Winners & Losers From Tuesday, August 26 Aug 26 2014
    Arrowhead Research (ARWR) Stock Rises on High Volume Aug 26 2014
    [video] $8.3 billion biotech deal Aug 25 2014
    ARROWHEAD RESEARCH CORP Financials Aug 19 2014
    ARWR: Arrowhead Reported Fiscal 2014 Third Quarter Financial Results with a Strong Balance Sheet Aug 18 2014
    Arrowhead Discloses First Human Hepatitis B Therapy Results Aug 12 2014
    ARROWHEAD RESEARCH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 12 2014
    Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 Aug 12 2014
    ARROWHEAD RESEARCH CORP Files SEC form 10-Q, Quarterly Report Aug 12 2014
    Q3 2014 ARROWHEAD RESH CORP Earnings Release - After Market Close Aug 12 2014
    Today's Dead Cat Bounce Stock Is Arrowhead Research (ARWR) Aug 04 2014
    Arrowhead to Report Fiscal 2014 Third Quarter Financial Results Jul 31 2014
    Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Perilous Reversal" Stock Jul 31 2014
    'Fast Money' Recap: Playing China Through U.S. Stocks Jul 29 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Truthtracer@twitter
    ReplyTruthtracer@twitter - 9 months ago
    Correction, carefully read the scientific foundation shared in the 4th quarter report.
    Truthtracer@twitter
    ReplyTruthtracer@twitter - 9 months ago
    Pay attention to the science in the third quarter report. Institutional holdings have increased from 30% to over 70% in 3 months. Reputable, longer term holders...
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK